You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Effectuez un dépistage du virus de l'hépatite B chez tous les patients cancéreux débutant un traitement systémique. Apprenez-en davantage sur le dépistage et la gestion du virus de l'hépatite B.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Regimen
Published Date: 02 Sep 2025
Intent: Neoadjuvant, Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gynecologic, 
Cervix
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025

Pages